SUMMARY: The notes of 3095 patients who attended the tuberculosis service of BM" Dharan between 1961 and 1982 were examined. Pulmonary tuberculosis accounted for 90% of cases. The overall rates of cure and default were 47% and 32% respectively. The reasons for default which mostly occurred within six months of starting treatment are examined. Changes in the policy of the service are suggested to make its operation more appropriate to its setting in a developing country.
Introduction
Tuberculosis (TB) especially pulmonary tuberculosis (PTB) is one of the greatest medical problems facing Nepal'. The prevalence of smear positive cases of PTB amounts to 3.5/1000 2 • The small British Military Hospital (BMH) at Dharan in eastern Nepal has operated a TB service since its opening in 1961. The service has steadily expanded to a current level where it consumes a large part of the medical resources.
The aims of this study were to attempt an audit of the service to allow comparison of its effectiveness with the other organisations treating TB in eastern Nepal, to identify problem areas, to suggest avenues for future improvement and to highlight differences in the approach to treatment which are necessary when treating TB in a developing country.
To put the TB service into context it is necessary to review briefly the general situation in Nepal. The country, which lies along the northern edge of India has a population of about 12, 570 ,000 with an annual increase of 2.5%3. It is broadly divided into three zones 3 • The southernmost is a fertile fiat plain (Terai) where 36.5% of the population live and which contains virtually all the motorable roads (3200 km). In the far north is the remote mountainous zone where 6 .5 % of the people live. Between the two and occupying most of the country is the area of the mid-hills. Here 57% of the popUlation live, many as subsistence farmers. All travel is by foot and during the monsoon travel in many areas is impossible.
The medical services are poorly developed. The doctor/population ratio is 1/42,778 and the hospital bed/population ratio is 1.7/1000 3 _ Several agencies are involved in treating TB in eastern Nepal. The govern-
• Now attached to St. Thomas's Hospital, London. ment has hospitals in the larger towns. Most have facilities for sputum smears but X-ray facilities are commonly absent. Not all hospitals have permanent medical staff. In the rural areas, health posts staffed by trained health assistants take the place of hospitals. Inadequate and irregular drug supply is the greatest threat to the government TB programme!. In practice most patients are required to buy drugs in the bazaar. Private practitioners also treat TB in the towns. Their prescribing is uncontrolled, all drugs being bought privately. The price of drugs currently available in the Dharan bazaar is given in Table J. Drug price must be related to the local economy. A labourer in Dharan might earn [10] [11] [12] [13] [14] [15] NCR daily The Nepalese government in conjunction with SCF and BNMT operate an agreed chemotherapy policy of streptomycin and ,thiazina for 60 days followed by thiazina alone for 10 months 3 • In the towns however the policy is ignored by private practitioners and it is not strictly adhered to at BMH.
t Method
The notes of all patients who attended the TB service at BMH Dharan since its opening in 1961 to December 1982 formed the basis of the study. The t separate storage of these notes aided the completeness of the data collection. Details of diagnosis, presentation, places of domicile, outcome and management were extracted from the clinical record. To amplify the radiological data in patients with PTB the presentation chest X-rays of 100 consecutive PTB patients were examined in more detail. The following definitions were used: 40-70. Most patients have at least one X-ray and many have a sputum smear. Although 69% of patients are managed as out-patients the TB inpatients made very major demands on the in-patient medical resources. Taking first admission alone the cumulative patient weeks of in-patient treatment amounted to 9134 patient-weeks. This figure includes only patients admitted to the acute medical wards or the low dependency wards and excludes those ~.c commodated in the medical hostel which is now supplied totally from BMH.
The diagnostic breakdown of attendances is given in Table n .
A PULMONARY TUBERCULOSIS (PTB) PTB was the outstanding problem and accounted for 90% of all cases. The sex ratio was in favour of men (2: 1) with a mean age of 31 years (range 0.25-86) for males and 26 years (range 0.25-68) for females. 7% of patients were aged less than 5 years at diagnosis. Local patients amounted to 24 % while 55 % were non-local (some came from as far as Pokhara to the west and as far as Assam to the east). Many of these patients travelled long distances by foot (some up to 10 days) to the hospital. In 21 % the place of domicile was not recorded.
Patients, unlike those in UK presented with far advanced disease. The mean duration of symptoms was surprisingly low at three months and probably represented the ,time from the appearance of an alarming symptom or more rapid decline in health superimposed upon a longer period of chronic ill health. Cough was present in 72%, fever in 51 %, chest pain in 37%, haemoptysis in 34%, weight loss in 18%, anorexia in 15%, dyspnoea in 14%, and laryngitis in 0.4 %. The low perceived prevalence of weight loss is interesting as considerable weight gain occurred during treatment. A minority presented with serious complications such as pneumothorax (1.6 %), large pleural effusion (4%), pyothorax (0.7%) or chest wall sinuses (0.5%). Sputum smears were recorded in 62 % of which 62 % were positive. The overall results of treatment are shown in Table Ill . Default from treatment because of its public health importance was examined further -see Table IV .
The chest X-ray appearance in 100 consecutive presentation chest X-rays were examined in detail, 63 were male and 37 female. There were 12 children under the age of 14 years. The children typically had unilateral hilar or para tracheal lymphadenopathy but • had in addition evidence of parenchymal involvement in 50%. In adults minimal apical disease was rare, the disease being usually very extensive. In 55% there was involvement of an equivalent of one entire lung field, in 21 % marked fibrosis and in 7% major
• destruction of a lung. Using very strict criteria which almost certainly underestimated the real incidence 29% had cavities. The mean internal cavity diameter was 22 mm with a wall thickness exceeding 3 mm in 13 patients. Pneumothorax was seen in 4 % and basal effusions in 10%. Apical pleural thickening or encysted effusion above a tuberculous upper lobe were seen in 24%. Three had miliary TB (all children).
• B TUBERCULOUS LYMPHADENOPATHY This was the commonest minority diagnosis. 280 cases were reported. It was a disease of older children (mean age 15 years) and equally common in males and females. Cervical disease was present in 94 %, axillary in 7% and inguinal in 3 % (those with disease in more than one site were recorded separately). The disease was often locally advanced (mean duration eight months) with multiple sinuses in 18% yet little in the way of systemic upset. PTB was also present in 31 % and 4 % had miliary TB. Diagnosis was usually based on a combination of clinical parameters and probability, only 5% being confirmed by excision biopsy. The outcome is shown in Table V . 
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The diagnosis was based upon typical chest X-ray appearances. 69 cases were recorded. Their mean age was surprisingly high (19 years) with only 24% aged under five years. The sex incidence was equal. Patients presented with a relatively brief illness (mean duration eight weeks) comprising fever 65%, cough 65%, weight loss 32%, anorexia 19%, chest pain 17 % and haemoptysis 8 %. In 13 % the presentation was tuberculous meningitis. Sputum smears were recorded in 30 patients of whom 27% were positive. 70% were managed as outpatients. The outcome is shown in Table VII . Fifty-eight patients were recorded. Their mean age was 23.8 years (range 1.5-67) with a male preponderance of 2: 1. The local disease was usually of long duration (mean 9.6 months) and advanced. They presented with local pain (100%), gibbus (55%), psoas or paraspinal abscess (31 %) or some degree of paraplegia (26 %). Radiological changes were seen in the dorsal vertebrae (59%), lumbar vertebrae (38%) and cervical vertebrae (8 %), (disease in more than one area was counted separately). Active PTB was detected in 33 %. The outcome is shown in Table VIII . 
F TUBERCULOUS MENINGITIS (TBM)
Only 23 cases confirmed by lumbar puncture were recorded which was surprisingly low. The disease was commonest in children (mean age 9.2 years) and more common in males (2: 1). The patients usually presented with far advanced neurological disease (mean duration four weeks) with marked depression of consciousness, established meningism and focal neurological signs. In 43 % there was chest X-ray evidence of PTB or miliary TB. On lumbar puncture CSF findings were typical with elevated protein in 95%, lymphocytosis in 91 % and reduction in sugar in 86%. Tubercle bacilli were rarely seen on microscopy. Some of the survivors had neurological sequelae. The outcome is shown in Table IX . Two hundred and twelve deaths directly due to TB were recorded of which 87 % occurred on the ward. The 13 % of home deaths represents an underestimate as the fate of patients not returning for follow-up (recorded as defaulters) was unknown and probably some at least would have died at home. There was an excess of deaths in males (78%) compared with that expected (SE diff. 3.5). In 115 cases death occurred during the initial admission of whom 52 % died within seven days. TB accounted for 20% of all hospital deaths.
H DEFAULT
Nine hundred and eight-five patients (32 %) defaulted. Their mean age was 29 years and default was proportionally commoner in males (3.4: I). 10%
were successfully retreated and 3 % are continuing therapy. Of the remaining 87% their fate is unknown, Some probably died from TB and others from other causes. It was however uncommon for concern ·to be raised about the patients' general condition at the clinic attendance immediately before default. 9% defaulted before starting treatment and 72 % defaulted within six months of starting therapy. Default according to category is shown in Table X . 
FAMILY OF SOLDIER
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OUT-PATIENTS 68% 69%
IN-PATIENTS
32% 31%
J BACTERIOLOGY The results of Ziehl-Neelsen (ZN) smears were not always recorded. Only in 10% of cases (mostly PTB) was culture attempted -see Table XI . 
K RELAPSE
One hundred and two patients (92 with PTB) were retreated for relapse. The mean time to relapse was 20 months. 50% were cured.
L COMPLIANCE
Evidence of poor compliance was taken from notes of the attending physician supported where possibk by objective data such as late clinic attendance or absence of PAS from urine. 237 cases were recorded (7.6%). Age and sex were not predictive. Compliance failure was followed by default in 57% of cases which was significantly more than the expected (SE diff 3.3).
M PROLONGED THERAPY
Some patients with resistant organisms or more often irregular tablet taking were treated for prolonged periods (some for more than 10 years). 273 (9%) were treated continuously for more than 24 months.
N THERAPY
In the early days of the service Streptomycin, PAS and INAH were standard drugs. In the mid seventies the standard drugs were changed to Streptomycin. INAH and Thiacetazone. A variety of other drugs were available and a non-standard regimen was used in 23 % of cases. The policy at present is to use Streptomycin and Thiazina (Thiacetazone/INAH combined preparation) for 60 days followed by Thiazina for another 16 months. Mono-therapy was never used except for chemoprophylaxis. A major change in therapy was recorded in 16% of cases which involved the addition of a single drug in 11 % of cases. More than five drugs were used during a single course of chemotherapy in 8 % of patients. Sideeffects severe enough to cause a change of drug occurred in 9 %. Age and sex did not seem predictive of side-effects which comprised rash (59%), nausea (26%), dizziness (16%), Stevens-lohnson syndrome (3.6%), impaired hearing (2.4%), goitre (2%), confusion (\.6%), jaundice (0.8%) and exfoliative dermatitis (0.8%). Four died from either exfoliation or Stevens-lohnson syndrome. It was often impossible to implicate a single drug but where the offending 27 drug was identifiable it was Thiazina 51 %, Streptomycin 23%, and PAS 10%. The development of sideeffects increased the chance of subsequent default.
Discussion
The TB service consumes a large portion of the available medical and investigative facilities of BMH Dharan. Although TB presents in a wide variety of forms the minor diagnoses will be dealt with briefly allowing a longer discussion of PTB.
Tuberculous lymphadenopathy was usually locally advanced and sometimes atypical with inguinal or generalised lymphadenopathy. Systemic illness was uncommon unless PTB coexisted (31 %). Treatment should be commenced on the basis of clinical impression and probability without recourse to biopsy unless there is serious diagnostic doubt. Abdominal TB was difficult to diagnose in the absence of PTB. To avoid unnecessary morbidity and exhaustion of resources, treatment should be started on clinical impression reserving laparotomy for cases of real doubt or complications. In this medical series ATB causing obstruction was under-represented because of patient selection. In those with ascites peritoneal biopsy using an Abrams pleural biopsy punch is useful and safe. Miliary TB and meningeal TB occurred mostly in younger patients and carried a significant mortality due to late presentation. Miliary TB was an important cause of undiagnosed fever and hepatosplenomegaly. In seriously ill patients and in the absence of adequate supplies of blood for transfusion bone marrow aspiration is a safer investigation than liver biopsy. Patients with meningeal TB usually presented with well marked meningitis and often focal neurological signs. The CSF findings were typical. Although from this study a therapeutic policy can not be defined, good results in later cases were obtained by an induction regimen of streptomycin (IM), isoniazid, rifampicin, pyrazinamide and decrementing prednisolone for eight weeks then rifampicin plus isoniazid for a further seven months. Orthopaedic TB was probably under reported because some of these patients were cared for solely by the surgeons. Spinal TB was usually very advanced locally but responded well to medical therapy without prolonged immobilisation. The milder neurological deficits tended to improve. The more severe forms were probably under represented as such patients were not often admitted.
Pulmonary TB was the oustanding problem. Although the age range was wide (0.25-86 years) most patients came from the economically productive part of society (mean age 29.6 years). Most had advanced cavitating disease, the early apical PTB typical of UK being rare.
The treatment policy employed at BMH evolved over the years to Streptomycin plus Thiazina for 60 days followed by Thiazina for another 16 months. Other anti-tuberculous were available and were used at the discretion of the attending physician.
The agreed national policy for treating TB in Nepal which is used in government hospitals and by BNMT and SCF is Streptomycin plus Thiazina for 60 days followed by Thiazina for another 10 months~. Logistically a shortened programme has many advantages and there seems little doubt that it should be adopted by BMH. Restricting treatment to Streptomycin and Thiazina reduces the development of resistance to second-line drugs and should be continued in accordance with national policy where possible. Second-line drugs however have an important role in treating drug resistant disease, those severely ill especially with tuberculous meningitis and those with serious complications such as pyothorax. The use of prednisolone is controversial but probably has a role in the treatment of meningeal TB, gross pleural effusions and in \:,ery ill patients4. In UK it is probably not necessary to use pyridoxine routinely to prevent isoniazid related peripheral neuropathy. It has been shown however that in undernourished subjects standard doses of isoniazid cause a high incidence of neuropathy5 so in Nepal routine use of pyridozine would seem sensible.
Standard chemotherapy as used in Nepal can produce cure rates of 90% 6 so the cure rate achieved by the BMH TB service of less than 50% seems at first disappointing. In the context of the developing world however cure rates of greater than 50% seem elusive and default rates remain high despite the great industry and motivation of TB programme users~·6. The reasons behind default are undoubtedly complex, involving health expectations, standards of general and health education, response to -treatment, unpleasant drug side-effects, motivation, distance from the treatment centre, season and domestic or social commitments. Elsewhere in Nepal irregular drug supply and the high cost of drugs are important causes. In this study factors predictive of default were the male sex, villager status (those with lowest educational standards and expectations) and the occurrence of drug side-effects. Age and type of TB seemed less important. Distance travelled from home to BMH surprisingly did not relate to the risk of default. It was not possible from the records to relate default to season especially the monsoon or planting seasons when travel is difficult or economically impossible. As demonstrated by others in east NepaP the bulk of default (72% in this series) occurred within the first six months presumably as symptoms subsided and general well-being returned. Some patients classified as defaulters probably died at home as the fate of those not attending follow-up was rarely established. Against this number being large however was the almost universal absence of serious decline in health as recorded in the notes just prior to default and a similar default-rate recorded by others l in Nepal. Reducing default is difficult. Clearly patient education with reinforcement at each clinic visit particularly during the vulnerable early months is essential. It is interesting to note however that in this series inpatients who were most exposed to health education and used to taking regular medicines defaulted just as often as out-patients. The default rate might have been increased by the national policy of using Streptomycin and Thiazina as standard ,therapy because of the high incidence of side-effects 7 but no change in this policy can be envisaged because of its cheapness. Some organisations employ individuals (chasers) to go out into the community to seek out defaulters. This system however could not easily be applied at BMH because only a minority of patients are local and the concept is probably outside the working brief of the hospital. A clear exception to this concerns LECs and patients living on the cantonment because of their interface with the British community. A register of such patients should be kept so defaulters can be rapidly detected and brought back for treatment. The physicians might further reduce default by considerate prescribing particularly avoiding appointments during the monsoon for patients living in the hills and avoiding appointments during the rice planting season for farmers. Poor compliance is a related problem and probably underestimated. Its detection is an important predicter of impending default and much increases the risk of drug resistance. Improving compliance follows the same lines as reducing default except that for local patients and probably all LECs and patients living on the camp insurance against poor compliance (but not default) can be achieved by using intermittent fully supervised therapy such as 12 months of Streptomycin (1 g) plus INAH (900 mg) plus pyridoxine (20 mg) twice weekly. This would not be inconsistent with the national policy and produces a good cure rate~. For those not supervised combined preparations should be used rather than two single agents to reduce the risk of inducing resistance following irregular drug taking.
. In addition ~o a massive morbidity TB has a sigmficant mortality. TB in all its forms accounted for 20% of all inpatient deaths in BMH. The number of deaths at home was an underestimate due to inadequate recording. Of the inpatient deaths most occurred within the first month of therapy. In some, ~arl~ death (52% within seven days) was probably mevltable due to the advanced disease but in others t?e ca~se was not obvious. Pulmonary embolus, septIcaemia secon?ary to impoverished immunity might be causes but m many the mechanism was unclear 9 . The demand for treatment of PTB in east Nepal far exceeds the available resources. The selection of patients .for treatment and duration of follow-up must be modified from UK standards to meet the local situation. Smear negative PTB is a smaller public health hazard than smear positive PTB and also carries a significantly better prognosis untreated 1o ,l1, 12. It might be reasonable to restrict treatment to smear positive cases only, with the exception of soldiers, LECs, cantonment dwellers and probably families of soldiers. The duration of standard therapy should be reduced to 12 months to come into line with national policy3 and extension beyond that limited to those with evidence of therapeutic failure (for whatever reason). Defining cure is difficult. It appears unnecessary to demand universally negative sputum smears in the six months before withdrawing chemotherapyl:1,14,15. The absence of clinical and Xray evidence of activity plus a negative sputum at the end of a full course of chemotherapy in the face of good compliance might be considered. To avoid unnecessary retreatment of patients criteria for diagnosing relapse are required. Relapse with fever, cough and haemoptysis can be mimicked by post-tuberculous bronchiectasis. Even the presence of an isolated positive sputum can not be taken as evidence of clinically significant relapse l6 • The BTA definition of two positive cultures taken not less than two weeks apart should be applied where possible. In such cases sensitivity testing is indicated as a relapse with organisms sensitive to first-line drugs can be successfully retreated with those drugs'1. In UK some follow-up to PTB patients is usual. In Nepal many patients do not attend follow-up clinics once drugs are stopped and those that do increase the burden on clinic time and on radiological and laboratory resources. Consideration should be given to abandoning routine follow-up of patients who have successfully completed a full course of chemotherapy as the chances of relapse are small l8 . Exceptions might be soldiers and Nepalese who come into direct contact with UK personnel e.g. LECs. Currently the TB service puts large demands on the X-ray department and bacteriology service. Chest X-rays are taken at most follow-up clinics and for in-patients chest Xrays are done monthly (more often if indicated). Sputum smears are routinely taken for each clinic visit and weekly for in-patients. It has become apparent however, especially in the context of developing countries that chest radiology has only a limited place in the assessment of therapy18. It seems of secondary importance to sputum smears. Much time and money could be saved by reducing routine chest X-rays. Although sputum smears give valuable evidence of therapeutic success or failure it has been shown that a smear taken at 5-6 months after starting therapy gives the most useful information 18 and that weekly or even monthly smears are not necessary and can be misleading. Routine sensitivity testing is not required because the prevalence of resistant organisms is still very low.
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BMH Dharan has never taken a large role in community preventive medicine. Some BCG immunisations are undertaken and should probably continue for Heaf negative PTB contacts living on the camp and babies born in the hospital but the extension of the service into the community is outside the brief of the hospital. Unlike in UK, contact tracing is not routinely done. In some cases it is geographically impossible and even with local patients it would greatly increase the already large workload without contributing much to general community health as the default rate in PTB patients in Nepal detected by contact tracing is over 70% 1.
In conclusion the following changes in policy at BMH might be considered: 1 Reducing the standard duration of treatment to 12 months. 2 Greatly reducing the use of chest X-rays and sputum smears used to assess progress while on therapy. 
